ID   OCLN_RAT                Reviewed;         523 AA.
AC   Q6P6T5; Q9Z303;
DT   16-MAY-2006, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   29-MAY-2024, entry version 137.
DE   RecName: Full=Occludin;
GN   Name=Ocln;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND FUNCTION.
RC   STRAIN=Sprague-Dawley; TISSUE=Liver;
RX   PubMed=11810420; DOI=10.1007/s007950050003;
RA   Atsumi Si S., Kokai Y., Tobioka H., Kuwahara K., Kuwabara H., Takakuwa Y.,
RA   Sasaki Ki K., Sawada N., Mitaka T., Mochizuki Y., Imai K., Mori M.;
RT   "Occludin modulates organization of perijunctional circumferential actin in
RT   rat endothelial cells.";
RL   Med. Electron Microsc. 32:11-19(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-371, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: May play a role in the formation and regulation of the tight
CC       junction (TJ) paracellular permeability barrier. May be involved in the
CC       organization of actin in endothelial cells.
CC       {ECO:0000269|PubMed:11810420}.
CC   -!- SUBUNIT: Interacts with TJP1/ZO1. Interacts with VAPA. Interacts with
CC       CLDN1, CLDN6, CLDN9, CLDN11, CLDN12 and CLDN17. Interacts with PLSCR1.
CC       Interacts with LSR, ILDR1 and ILDR2. Interacts with TJP2/ZO2 (By
CC       similarity). {ECO:0000250|UniProtKB:Q16625,
CC       ECO:0000250|UniProtKB:Q61146}.
CC   -!- INTERACTION:
CC       Q6P6T5; O35346: Ptk2; NbExp=2; IntAct=EBI-15348891, EBI-6252940;
CC       Q6P6T5; F1M4A0: Tjp1; NbExp=2; IntAct=EBI-15348891, EBI-15783773;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q16625};
CC       Multi-pass membrane protein {ECO:0000255}. Cell junction, tight
CC       junction {ECO:0000250|UniProtKB:Q16625}.
CC   -!- DOMAIN: The C-terminal is cytoplasmic and is important for interaction
CC       with ZO-1. Sufficient for the tight junction localization. Involved in
CC       the regulation of the permeability barrier function of the tight
CC       junction (By similarity). {ECO:0000250}.
CC   -!- PTM: Dephosphorylated by PTPRJ. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the ELL/occludin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB016425; BAA36681.1; -; mRNA.
DR   EMBL; BC062037; AAH62037.1; -; mRNA.
DR   RefSeq; NP_112619.2; NM_031329.2.
DR   RefSeq; XP_006231915.1; XM_006231853.3.
DR   RefSeq; XP_006231916.1; XM_006231854.3.
DR   RefSeq; XP_006231917.1; XM_006231855.3.
DR   AlphaFoldDB; Q6P6T5; -.
DR   SMR; Q6P6T5; -.
DR   BioGRID; 249716; 2.
DR   CORUM; Q6P6T5; -.
DR   DIP; DIP-48891N; -.
DR   IntAct; Q6P6T5; 2.
DR   STRING; 10116.ENSRNOP00000024674; -.
DR   iPTMnet; Q6P6T5; -.
DR   PhosphoSitePlus; Q6P6T5; -.
DR   PaxDb; 10116-ENSRNOP00000024674; -.
DR   Ensembl; ENSRNOT00000024674.6; ENSRNOP00000024674.4; ENSRNOG00000018297.6.
DR   Ensembl; ENSRNOT00055050200; ENSRNOP00055041312; ENSRNOG00055028978.
DR   Ensembl; ENSRNOT00065039377; ENSRNOP00065032006; ENSRNOG00065023023.
DR   GeneID; 83497; -.
DR   KEGG; rno:83497; -.
DR   AGR; RGD:620089; -.
DR   CTD; 100506658; -.
DR   RGD; 620089; Ocln.
DR   eggNOG; ENOG502QS9F; Eukaryota.
DR   GeneTree; ENSGT00940000155771; -.
DR   HOGENOM; CLU_039628_1_0_1; -.
DR   InParanoid; Q6P6T5; -.
DR   OrthoDB; 5360956at2759; -.
DR   TreeFam; TF326161; -.
DR   Reactome; R-RNO-351906; Apoptotic cleavage of cell adhesion proteins.
DR   PRO; PR:Q6P6T5; -.
DR   Proteomes; UP000002494; Chromosome 2.
DR   Bgee; ENSRNOG00000018297; Expressed in jejunum and 18 other cell types or tissues.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:RGD.
DR   GO; GO:0016327; C:apicolateral plasma membrane; ISO:RGD.
DR   GO; GO:0005923; C:bicellular tight junction; ISO:RGD.
DR   GO; GO:0030054; C:cell junction; ISO:RGD.
DR   GO; GO:0005911; C:cell-cell junction; ISO:RGD.
DR   GO; GO:0031410; C:cytoplasmic vesicle; ISO:RGD.
DR   GO; GO:0030139; C:endocytic vesicle; ISO:RGD.
DR   GO; GO:0016328; C:lateral plasma membrane; IDA:RGD.
DR   GO; GO:0005765; C:lysosomal membrane; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0032991; C:protein-containing complex; ISO:RGD.
DR   GO; GO:0070160; C:tight junction; ISO:RGD.
DR   GO; GO:0019904; F:protein domain specific binding; ISO:RGD.
DR   GO; GO:0070830; P:bicellular tight junction assembly; ISO:RGD.
DR   GO; GO:0045216; P:cell-cell junction organization; ISO:RGD.
DR   GO; GO:0071356; P:cellular response to tumor necrosis factor; IEP:RGD.
DR   GO; GO:0010629; P:negative regulation of gene expression; ISO:RGD.
DR   GO; GO:0001933; P:negative regulation of protein phosphorylation; ISO:RGD.
DR   GO; GO:1905605; P:positive regulation of blood-brain barrier permeability; ISO:RGD.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISO:RGD.
DR   GO; GO:0046326; P:positive regulation of glucose import; ISO:RGD.
DR   GO; GO:0010827; P:regulation of glucose transmembrane transport; ISO:RGD.
DR   GO; GO:0140459; P:response to Gram-positive bacterium; IEP:RGD.
DR   GO; GO:0070673; P:response to interleukin-18; IMP:RGD.
DR   GO; GO:0120193; P:tight junction organization; ISO:RGD.
DR   Gene3D; 6.10.140.340; -; 1.
DR   InterPro; IPR031176; ELL/occludin.
DR   InterPro; IPR008253; Marvel.
DR   InterPro; IPR002958; Occludin.
DR   InterPro; IPR010844; Occludin_ELL.
DR   PANTHER; PTHR23288:SF4; OCCLUDIN; 1.
DR   PANTHER; PTHR23288; OCCLUDIN AND RNA POLYMERASE II ELONGATION FACTOR ELL; 1.
DR   Pfam; PF01284; MARVEL; 1.
DR   Pfam; PF07303; Occludin_ELL; 1.
DR   PIRSF; PIRSF005993; Occludin; 1.
DR   PRINTS; PR01258; OCCLUDIN.
DR   SUPFAM; SSF144292; occludin/ELL-like; 1.
DR   PROSITE; PS51225; MARVEL; 1.
DR   PROSITE; PS51980; OCEL; 1.
PE   1: Evidence at protein level;
KW   Cell junction; Cell membrane; Coiled coil; Disulfide bond; Membrane;
KW   Phosphoprotein; Reference proteome; Tight junction; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..523
FT                   /note="Occludin"
FT                   /id="PRO_0000236103"
FT   TOPO_DOM        1..66
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        67..87
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        88..140
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        141..161
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        162..173
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        174..194
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        195..244
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        245..265
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        266..523
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          60..269
FT                   /note="MARVEL"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00581"
FT   DOMAIN          415..523
FT                   /note="OCEL"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01324"
FT   REGION          1..20
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          302..338
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          363..408
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          433..489
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        364..381
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        388..405
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         302
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q61146"
FT   MOD_RES         305
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q61146"
FT   MOD_RES         313
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q16625"
FT   MOD_RES         321
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q16625"
FT   MOD_RES         340
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q61146"
FT   MOD_RES         360
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q61146"
FT   MOD_RES         369
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q16625"
FT   MOD_RES         370
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q16625"
FT   MOD_RES         371
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         399
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q16625"
FT   MOD_RES         403
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q16625"
FT   MOD_RES         404
FT                   /note="Phosphothreonine; by PKC/PRKCH"
FT                   /evidence="ECO:0000250|UniProtKB:Q16625"
FT   MOD_RES         405
FT                   /note="Phosphothreonine; by PKC/PRKCH"
FT                   /evidence="ECO:0000250|UniProtKB:Q16625"
FT   MOD_RES         409
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q16625"
FT   MOD_RES         491
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q16625"
FT   DISULFID        216..237
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   CONFLICT        276
FT                   /note="K -> R (in Ref. 1; BAA36681)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   523 AA;  59186 MW;  A31E007B58AEA5B5 CRC64;
     MSVRPFESPP PYRPDEFKPN HYAPSNDMYG GEMHVRPMLS QPAYSFYPED EILHFYKWTS
     PPGVIRILSM LVIVMCIAVF ACVASTLAWD RAYGTGIFGG SMNYPYGSGF GSYGGGFGGY
     GYGYGYGYGG YTDPRAAKGF LLAMAAFCFI ASLVIFVTSV IRSGMSRTRR YYLIVIIVSA
     ILGIMVFIAT IVYIMGVNPT AQASGSMYGS QIYTICSQFY TPGGTGLYVD QYLYHYCVVD
     PQEAIAIVLG FMIIVAFALI IVFAVKTRRK MDRYDKSNIL WDKEHIYDEQ PPNVEEWVKN
     VSAGTQDMPP PPSDYAERVD SPMAYSSNGK VNGKRSYPDS LYKSPPLVPE VAQEIPLTLS
     VDDFRQPRYS SNDNLETPSK RTPTKGKAGK AKRTDPDHYE TDYTTGGESC DELEEDWLRE
     YPPITSDQQR QLYKRNFDAG LQEYKSLLAE LDEVNKELSR LDRELDDYRE ESEEYMAAAD
     EYNRLKQVKG SADYKSKKNY CKQLKSKLSH IKRMVGDYDR RKT
//
